Portico Next Generation Approval Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 333 participants.

Also called NCT04011722

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 333 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04011722
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Denmark, Italy, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04011722. Non-randomized; no masking; primary purpose treatment. Start 2019-09-17 (actual); primary completion 2023-01-12 (actual). Results posted on 2024-07-01.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Portico Next Generation Approval Study
Condition
Symptomatic Severe Aortic Stenosis
Intervention (Device)
Portico™ NG (Navitor) Valve and FlexNav™ Delivery System
Intervention (Device)
Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct04011722
Content hash
a1ac592c48c8442009ebbfb3f11136ebb7fa3e9d5a59f3f0e87ddd38c63dd80c